- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sun Pharmaceutical Industries Limited is conducting a Postal Ballot/E-voting to obtain shareholder approval for significant related party transactions involving its subsidiaries. The voting process begins on 24 February 2025 and concludes on 25 March 2025, with results expected by 27 March 2025. Key transactions include approvals for funding arrangements and revenue contracts between Taro Pharmaceuticals and Sun Pharmaceutical for a cumulative amount of approximately USD 1.295 billion (INR 109,695 million) for the fiscal year 2025-26. This move aims to enhance operational efficiency and group integration, potentially fostering a positive outlook for investors by reinforcing strategic collaboration within the company’s subsidiaries.
All announcements from Sun Pharmaceutical Industries Limited